Description

Protein engineering is the process by which a researcher modifies a protein sequence through substitution, insertion, or deletion of nucleotides in the encoding gene, with the goal of obtaining a modified protein that is more suitable for a particular application or purpose than the unmodified protein. The global protein engineering market is poised to grow by US$ 1,099.2 million from 2022 to 2028, registering a CAGR of 9.2% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for protein engineering. The global protein engineering market is segmented on the basis of product, technology, application, end user, and region. By product, the global protein engineering market has been segmented into instruments, reagents, software & services. In 2021, the reagents segment made up the largest share of revenue generated by the protein engineering market. Based upon technology, the global protein engineering market is categorized into directed evolution, rational protein design. The rational protein design segment was the largest contributor to the global protein engineering market in 2021. On the basis of application, the global protein engineering market has been segmented into coagulation factors, colony stimulating factors, growth factors, insulin, interferon, monoclonal antibodies, vaccines, others. By end user, the global protein engineering market has been segmented into academic & research institutes, contract research organizations (CROs), pharmaceutical & biopharmaceutical companies. The pharmaceutical & biopharmaceutical companies segment held the largest share of the global protein engineering market in 2021 and is anticipated to hold its share during the forecast period. In terms of geography, the global protein engineering market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global protein engineering market is highly competitive. As of 2021, the major players in the global protein engineering market were Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, GenScript Biotech Corporation, Merck KGaA, PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the protein engineering market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: instruments, reagents, software & services
Technology: directed evolution, rational protein design
Application: coagulation factors, colony stimulating factors, growth factors, insulin, interferon, monoclonal antibodies, vaccines, others
End user: academic & research institutes, contract research organizations (CROs), pharmaceutical & biopharmaceutical companies
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global protein engineering market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Protein engineering market overview
Part 3. Market breakdown by product
– Instruments
– Reagents
– Software & services
Part 4. Market breakdown by technology
– Directed evolution
– Rational protein design
Part 5. Market breakdown by application
– Coagulation factors
– Colony stimulating factors
– Growth factors
– Insulin
– Interferon
– Monoclonal antibodies
– Vaccines
– Others
Part 6. Market breakdown by end user
– Academic & research institutes
– Contract research organizations (CROs)
– Pharmaceutical & biopharmaceutical companies
Part 7. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 8. Key companies
– Agilent Technologies, Inc.
– Bio-Rad Laboratories Inc.
– Bruker Corporation
– Danaher Corporation
– GenScript Biotech Corporation
– Merck KGaA
– PerkinElmer Inc.
– Promega Corporation
– Thermo Fisher Scientific Inc.
– Waters Corporation
About StrategyHelix
Disclaimer